Sensorion
Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.
ALSEN | PA
Overview
Corporate Details
- ISIN(s):
- FR0012596468 (+2 more)
- LEI:
- 969500P0W8XJ9CGZDP97
- Country:
- France
- Address:
- 375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER
- Website:
- https://www.sensorion.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Sensorion is a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to address hearing loss disorders, a significant global unmet medical need. The company's mission is to restore, treat, and prevent inner ear pathologies through a three-pillar strategy. This approach includes developing gene therapies for genetic forms of hearing loss (Restore), creating innovative small molecule therapeutic solutions (Treat), and establishing targeted programs to prevent non-genetic hearing damage (Prevent). Sensorion leverages a unique R&D technology platform to advance its understanding of the pathophysiology and etiology of inner ear diseases, enabling the development of a cutting-edge therapeutic portfolio.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 07:30 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 253.3 KB | ||
| 2025-09-17 07:30 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 273.6 KB | ||
| 2025-09-04 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 168.5 KB | ||
| 2025-09-04 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 174.1 KB | ||
| 2025-08-15 07:30 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 139.2 KB | ||
| 2025-08-15 07:30 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 140.2 KB | ||
| 2025-07-29 07:30 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 188.2 KB | ||
| 2025-07-29 07:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 192.0 KB | ||
| 2025-07-01 07:30 |
Earnings Release
Inside Information / Other news releases
|
English | 187.9 KB | ||
| 2025-07-01 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 194.8 KB | ||
| 2025-05-13 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 133.2 KB | ||
| 2025-05-13 07:30 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 139.4 KB | ||
| 2025-05-06 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 180.6 KB | ||
| 2025-05-06 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 176.8 KB | ||
| 2025-04-25 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 151.9 KB |
Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sensorion
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sensorion via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-11 | N/A | Other | Other | 2,781,914 | 1,752,605.82 EUR |
| 2024-04-11 | N/A | Other | Other | 1,587,301 | 999,999.63 EUR |
| 2024-02-13 | N/A | Other | Other | 16,842,105 | 9,599,999.85 EUR |
| 2024-02-08 | N/A | Other | Other | 12,280,701 | 6,999,999.57 EUR |
| 2023-08-08 | N/A | Other | Other | 46,428,571 | 12,999,999.88 EUR |
| 2023-08-03 | N/A | Other | Other | 25,000,000 | 7,000,000.00 EUR |
Peer Companies
